List of works - Armando López-Guillermo

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

article

A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma

scientific article published on 19 September 2020

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

scientific article

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

scientific article

Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

scientific article published on 16 November 2020

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

scientific article published on 12 December 2018

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma

scientific article published on 18 December 2012

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

article

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

scientific article

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

article

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.

scientific article published on 25 August 2015

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

scientific article published on 26 July 2005

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

scientific article

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

scientific article published on 29 March 2017

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

scientific article published in April 2018

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption

scientific article published on 4 July 2014

Hematologic malignancies in patients with cryoglobulinemia: Association with autoimmune and chronic viral diseases

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

scientific article

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

scientific article

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

scientific article published in May 2010

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

scientific article published on 21 October 2013

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

scientific article published on 20 April 2017

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

scientific article published on 5 February 2016

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

scientific article published on 22 February 2019

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

scientific article

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features

scientific article published on 20 August 2012

Mutational Landscape and Tumor Burden Assessed by Cell-Free DNA in Diffuse Large B-Cell Lymphoma in a Population-based Study

scientific article published on 29 October 2020

Non-coding recurrent mutations in chronic lymphocytic leukaemia

scientific article published in Nature

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

scientific article

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

scientific article published on 7 August 2017

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

scientific article

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

scientific article published on 12 February 2007

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

scientific article

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

scientific article published on 02 November 2020

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

scientific article published on 21 May 2018

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

scientific article

Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection

scientific article published in January 2004

Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.

scientific article published on March 2004

List of works by Armando López-Guillermo

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption

Hematologic malignancies in patients with cryoglobulinemia: Association with autoimmune and chronic viral diseases

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features

Mutational Landscape and Tumor Burden Assessed by Cell-Free DNA in Diffuse Large B-Cell Lymphoma in a Population-based Study

Non-coding recurrent mutations in chronic lymphocytic leukaemia

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection

Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.